Trial intelligence / Profile preview

Continuous vs Intermittent Hydrocortisone in Septic Shock

NCT07695337Phase 4Completed

Sponsor
Benha University
Start
Jan 2026
Primary completion
Jul 2026
Countries
1
01

Overview

A Phase 4 trial of hydrocortisone in septic shock, sponsored by Benha University. Started Jan 2026; status: completed.

02

Drugs

hydrocortisone
03

Conditions

septic shock

Beyond the preview

Go deeper on NCT07695337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07695337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call